| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |